Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 5184-5190

  Van der Voort, Eileene Rouppe ^a   Van Dijken, Harry ^a   Kuipers, Betsy ^a   Van der Biezen, Jenny ^a   Van der Ley, Peter ^a   Meylis, Jolanda ^b   Claassen, Ivo ^b   Poolman, Jan ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; PORIN;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MEMBRANE VESICLE; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY;

EID: 0030775357     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.5184-5190.1997     Document Type: Article

References (27)

1. Bjune, G., E. A. Høiby, J. K. Grønnesby, O. Arnesen, J. H. Frederiksen, A. Halstensen, et al. 1991. Effect of an outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
2. Claassen, I., J. Meylis, P. van der Ley, C. Peeters, H. Brons, J. Robert, D. Borsboom, A. van der Ark, I. van Straaten, P. Roholl, B. Kuipers, and J. Poolman. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14:1001-1008.
3. Finne, J., D. Bitter-Suerman, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:4402-4407.
4. Frasch, C. E. 1985. Status of a group B Neisseria meningitidis vaccine. Eur. J. Clin. Microbiol. 4:533-536.
5. Frasch, C. E. 1989. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2:S134-S138.
6. Holten, E. 1979. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J. Clin. Microbiol. 9:186-188.
7. Maiden, M. C. J., J. A. Byrgraves, J. McCarvill, and I. M. Feavers. 1992. Identification of meningococcal serosubtypes by polymerase chain reaction. J. Clin. Microbiol. 30:2835-2841.
8. McGuinness, B., A. K. Barlow, I. N. Clarke, J. E. Farley, A. Anilionis, J. T. Poolman, and J. E. Heckels. 1990. Deduced amino acid analysis of class 1 protein (PorA) from three strains of Neisseria meningitidis: synthetic peptides define the epitopes responsible for serosubtype specificity. J. Exp. Med. 171:1871-1882.
9. McGuinness, B. T., I. N. Clarke, P. R. Lambden, A. K. Barlow, J. T. Poolman, D. M. Jones, and J. Heckels. 1991. Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet 337:514-517.
10. Mead, D. A., and B. Kemper. 1988. Chimeric single-stranded DNA phage-plasmid cloning vectors, p. 85-102. In R. L. Rodriguez and D. T. Denhardt (ed.), Vectors: a survey of molecular cloning vectors and their uses. Butterworth, Boston, Mass.
11. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. Melles, V. S. Vieira, H. Sato, G. S. Brito, J. C. Moraes, and C. E. Frasch. 1994. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
12. Peeters, C. C. A. M., H. C. Rümke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J, Kuipers, P. van der Ley, and J. T. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009-1015.
13. Peltola, H. 1984. Meningococcal disease: still with us. Rev. Infect. Dis. 5:71-91.
14. Poolman, J. T. 1995. Development of a meningococcal vaccine (review). Infect. Agents Dis. 4:13-28.
15. Rosenqvist, E., E. A. Høiby, E. Wedege, D. A. Caugant, L. O. Frohølm, B. T. McGuinness, J. Brooks, P. R. Lambden, and J. E. Heckels. 1993. A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine. Microb. Pathog. 15:197-205.
16. Rosenqvist, E., E. A. Høiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Rønnild, G. Bjune, and H. Noøkleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
17. Rouppe van der Voort, E., P. van der Ley, J. van der Biezen, S. George, O. Tunnela, H. van Dijken, B. Kuipers, and J. Poolman. 1996. Specificity of human bactericidal antibodies induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect. Immun. 64:2745-2751.
18. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
19. Scholten, R. J. P. M., H. A. Bijlmer, J. T. Poolman, A. J. Kuipers, D. A. Caugant, L. van Alphen, J. Dankert, and H. A. Valkenburg. 1993. Meningococcal disease in The Netherlands, 1958-1990. Steady increase of the incidence rate since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin. Infect. Dis. 16:237-246.
20. Suker, J., I. M. Feavers, and M. C. J. Maiden. 1996. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design. Microbiology 142:63-69.
21. Tommassen, J., P. Vermeij, M. Struyvé, R. Benz, and J. T. Pool man. 1990. Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and class 3 (PorB) outer membrane proteins. Infect. Immun. 58:1355-1350.
22. van der Ley, P. A., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963-2971.
23. van der Ley, P. A., and J. T. Poolman. 1992. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect. Immun. 60:3156-3161.
24. van der Ley, P. A., J. van der Biezen, P. Hohenstein, C. Peeters, and J. T. Poolman. 1993. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis. Infect. Immun. 61:4217-4224.
25. van der Ley, P. A., J. van der Biezen, and J. T. Poolman. 1995. Construction of Niseeria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 13:401-407.
26. Wedege, E., R. Dalseg, D. A. Caugant, J. T. Poolman, and L. O. Frøholm. 1993. Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteins. J. Med. Microbiol. 38:23-28.
27. Wyle F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunological response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-522.